专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06596863B2 Medical composition containing nitroetheneamine Derivative or salt there of as active constituent 失效
标题翻译：含有硝基乙烯胺的药物组合物作为活性成分的衍生物或盐
公开(公告)号：US06596863B2
公开(公告)日：2003-07-22
申请号：US10133752
申请日：2002-04-29
申请人： Fuminori Kato , Keizo Miyata , Hirohiko Kimura , Kazuhiro Yamamoto , Hiroyuki Ikegami , Hiromi Takeo
发明人： Fuminori Kato , Keizo Miyata , Hirohiko Kimura , Kazuhiro Yamamoto , Hiroyuki Ikegami , Hiromi Takeo
IPC分类号： C07D21376
CPC分类号： C07D495/04 , A61K31/00 , A61K31/428 , C07C243/16 , C07C243/20 , C07C243/22 , C07C243/28 , C07C243/38 , C07C251/76 , C07C251/80 , C07C251/86 , C07C257/06 , C07C281/02 , C07C311/49 , C07C311/51 , C07C323/36 , C07C327/58 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07D213/40 , C07D213/53 , C07D213/74 , C07D213/77 , C07D215/38 , C07D231/38 , C07D231/56 , C07D233/52 , C07D239/42 , C07D239/52 , C07D239/94 , C07D241/44 , C07D251/46 , C07D263/58 , C07D277/82 , C07D295/125 , C07D295/30 , C07D307/40 , C07D307/52 , C07D307/88 , C07D317/58 , C07D317/66 , C07D319/18 , C07D333/20 , C07D333/22 , C07D401/12 , C07D405/12 , C07D471/04
摘要： Process for producing a nitroetheneamine derivative or its stereoisomer, its tautomer or a salt thereof comprising reacting a compound of the formula with a compound of the formula R6—CH2NO2 to obtain a compound of the formula and reacting the resulting compound with a compound of the formula
摘要翻译：制备硝基乙烯胺衍生物或其立体异构体，其互变异构体或其盐的方法包括使制备式R 6 -CH 2 NO 2的化合物的化合物与式R 6 -CH 2 NO 2化合物反应，得到下式化合物，并使所得化合物与式

2. 发明授权

US06451792B1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent 失效
标题翻译：含有硝基乙烯胺衍生物或其盐作为活性成分的医药组合物
公开(公告)号：US06451792B1
公开(公告)日：2002-09-17
申请号：US09805781
申请日：2001-03-20
申请人： Fuminori Kato , Keizo Miyata , Hirohiko Kimura , Kazuhiro Yamamoto , Hiroyuki Ikegami , Hiromi Takeo
发明人： Fuminori Kato , Keizo Miyata , Hirohiko Kimura , Kazuhiro Yamamoto , Hiroyuki Ikegami , Hiromi Takeo
IPC分类号： A61K31135
CPC分类号： C07D495/04 , A61K31/00 , A61K31/428 , C07C243/16 , C07C243/20 , C07C243/22 , C07C243/28 , C07C243/38 , C07C251/76 , C07C251/80 , C07C251/86 , C07C257/06 , C07C281/02 , C07C311/49 , C07C311/51 , C07C323/36 , C07C327/58 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07D213/40 , C07D213/53 , C07D213/74 , C07D213/77 , C07D215/38 , C07D231/38 , C07D231/56 , C07D233/52 , C07D239/42 , C07D239/52 , C07D239/94 , C07D241/44 , C07D251/46 , C07D263/58 , C07D277/82 , C07D295/125 , C07D295/30 , C07D307/40 , C07D307/52 , C07D307/88 , C07D317/58 , C07D317/66 , C07D319/18 , C07D333/20 , C07D333/22 , C07D401/12 , C07D405/12 , C07D471/04
摘要： A medical composition containing, as an active constituent, a nitroetheneamine derivative represented by the formula (I): wherein the substituents are as defined in the disclosure, its stereoisomers, its tautomers or a salt thereof.
摘要翻译：作为活性成分含有由式（I）表示的硝基乙烯胺衍生物的医药组合物，其中取代基如本公开内容所定义，其立体异构体，其互变异构体或其盐。

3. 发明申请

US20070219215A1 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both 有权
标题翻译：硫胺及其盐及含有两者的细胞因子抑制剂
公开(公告)号：US20070219215A1
公开(公告)日：2007-09-20
申请号：US10588859
申请日：2005-02-16
申请人： Fuminori Kato , Hirohiko Kimura , Kiyoshi Tamai , Kazuhiro Yamamoto , Mitsuo Sano , Shinya Mori , Takashi Okada , Toshihiko Ueki , Kumiko Azuma
发明人： Fuminori Kato , Hirohiko Kimura , Kiyoshi Tamai , Kazuhiro Yamamoto , Mitsuo Sano , Shinya Mori , Takashi Okada , Toshihiko Ueki , Kumiko Azuma
IPC分类号： A61K31/496 , A61K31/16 , A61K31/44 , C07D213/00 , C07D401/00 , C07C327/02 , A61K31/445
CPC分类号： C07D239/34 , C07C233/66 , C07C233/69 , C07C233/71 , C07C233/78 , C07C323/42 , C07C327/48 , C07C2603/74 , C07D213/83 , C07D239/42
摘要： To provide cytokine production inhibitors useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions. A cytokine production inhibitor containing, as an active ingredient, a thioamide compound represented by the formula (I) or a salt thereof: wherein A is N, NO, C—NO2 or C—CN; Hal is a halogen; M1 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heterocyclyl, amino, O, S, SO or SO2; M2 is amino, O, S or a single bond; R1 is a halogen, alkyl or the like; each of R2, R3, R4 and R5 is independently H, alkyl or the like; R6 is a halogen, alkyl or the like; Cy is cycloalkyl, cycloalkenyl, aryl or heterocyclyl; each of k, p and q is independently an integer of from 0 to 3; and r is an integer of from 0 to 5.
摘要翻译：提供可用作预防或治疗药物的细胞因子产生抑制剂，用于伴有过度活化的免疫功能的疾病。含有式（I）所示的硫代酰胺化合物或其盐作为活性成分的细胞因子产生抑制剂：其中A为N，NO，C-NO 2或C-CN; 卤素是卤素; M 1是烷基，烯基，炔基，环烷基，环烯基，芳基，杂环基，氨基，O，S，SO或SO 2。 M 2是氨基，O，S或单键; R 1是卤素，烷基等; R 2，R 3，R 4和R 5各自独立地为H，烷基等; R 6是卤素，烷基等; Cy是环烷基，环烯基，芳基或杂环基; k，p和q各自独立地为0〜3的整数; r为0〜5的整数。

4. 发明授权

US07632865B2 Thioamides and salts thereof and cytokine production inhibitors containing both 有权
标题翻译：硫胺及其盐和含有这两者的细胞因子产生抑制剂
公开(公告)号：US07632865B2
公开(公告)日：2009-12-15
申请号：US10588859
申请日：2005-02-16
申请人： Fuminori Kato , Hirohiko Kimura , Kiyoshi Tamai , Kazuhiro Yamamoto , Mitsuo Sano , Shinya Mori , Takashi Okada , Toshihiko Ueki , Kumiko Azuma
发明人： Fuminori Kato , Hirohiko Kimura , Kiyoshi Tamai , Kazuhiro Yamamoto , Mitsuo Sano , Shinya Mori , Takashi Okada , Toshihiko Ueki , Kumiko Azuma
IPC分类号： A61K31/165 , C07C327/42
CPC分类号： C07D239/34 , C07C233/66 , C07C233/69 , C07C233/71 , C07C233/78 , C07C323/42 , C07C327/48 , C07C2603/74 , C07D213/83 , C07D239/42
摘要： To provide cytokine production inhibitors useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions.A cytokine production inhibitor containing, as an active ingredient, a thioamide compound represented by the formula (I) or a salt thereof: wherein A is N, NO, C—NO2 or C—CN; Hal is a halogen; M1 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heterocyclyl, amino, O, S, SO or SO2; M2 is amino, O, S or a single bond; R1 is a halogen, alkyl or the like; each of R2, R3, R4 and R5 is independently H, alkyl or the like; R6 is a halogen, alkyl or the like; Cy is cycloalkyl, cycloalkenyl, aryl or heterocyclyl; each of k, p and q is independently an integer of from 0 to 3; and r is an integer of from 0 to 5.
摘要翻译：提供可用作预防或治疗药物的细胞因子产生抑制剂，用于伴有过度活化的免疫功能的疾病。 1.一种细胞因子产生抑制剂，含有作为活性成分的式（I）所示的硫代酰胺化合物或其盐：其中A为N，NO，C-NO 2或C-CN; 卤素是卤素; M 1是烷基，烯基，炔基，环烷基，环烯基，芳基，杂环基，氨基，O，S，SO或SO 2; M2是氨基，O，S或单键; R1是卤素，烷基等; R2，R3，R4和R5各自独立地为H，烷基等; R6是卤素，烷基等; Cy是环烷基，环烯基，芳基或杂环基; k，p和q各自独立地为0〜3的整数; r为0〜5的整数。

5. 发明授权

US07067520B2 Preventive or therapeutic medicines for diabetes containing fused-heterocyclic compounds or their salts 失效
标题翻译：含有稠合杂环化合物或其盐的糖尿病的预防或治疗药物
公开(公告)号：US07067520B2
公开(公告)日：2006-06-27
申请号：US10416164
申请日：2001-11-15
申请人： Fuminori Kato , Hirohiko Kimura , Masato Omatsu , Kazuhiro Yamamoto , Ryuji Miyamoto
发明人： Fuminori Kato , Hirohiko Kimura , Masato Omatsu , Kazuhiro Yamamoto , Ryuji Miyamoto
IPC分类号： C07D487/04 , A61K31/519 , A61P3/10 , A61P3/06 , A61P9/00
CPC分类号： C07D487/04 , A61K31/519
摘要： The present invention provides a preventive or therapeutic medicine for diabetes containing as an active ingredient a fused-heterocyclic compound of the formula (I′) or its salt: [wherein G is CN, NO2, CO2R4, CHO, SO2NRaRb or CONRaRb; R1 is a halogen atom, a —O—R5 group or a —S—R5 group; R2 is a halogen atom, a —O—R5 group (wherein R5 is as defined above) or an amino group which may be substituted; and each of R8 and R10 which are independent of each other, is a hydrogen atom, a halogen atom or an alkyl group].
摘要翻译：本发明提供了含有作为活性成分的式（I'）的稠合杂环化合物或其盐的糖尿病预防或治疗药物：[其中G为CN，NO 2，CO， 2，2，4，4，...，...，...，... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... > a R ^{b ; R 1是卤素原子，-O-R 5基团或-S-R 5+基团; R 2是卤原子，-OR 5基团（其中R 5如上定义）或可被取代的氨基 ; 并且彼此独立的R 8和R 10各自为氢原子，卤原子或烷基]。}

6. 发明授权

US07132546B2 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same 失效
标题翻译：苯胺衍生物或其盐和含有它们的细胞因子产生抑制剂
公开(公告)号：US07132546B2
公开(公告)日：2006-11-07
申请号：US10451101
申请日：2001-12-21
申请人： Fuminori Kato , Hirohiko Kimura , Shunji Yuki , Kazuhiro Yamamoto , Takashi Okada
发明人： Fuminori Kato , Hirohiko Kimura , Shunji Yuki , Kazuhiro Yamamoto , Takashi Okada
IPC分类号： C07D213/64
CPC分类号： C07D213/40 , A61K31/04 , A61K31/15 , A61K31/167 , A61K31/18 , A61K31/428 , A61K31/44 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/496 , A61K31/505 , A61K31/5375 , C07C233/65 , C07C233/66 , C07C233/75 , C07C233/76 , C07C233/80 , C07C235/56 , C07C235/64 , C07C245/08 , C07C255/57 , C07C311/21 , C07C311/46 , C07C311/51 , C07C323/42 , C07C2601/14 , C07C2602/08 , C07C2603/74 , C07D213/61 , C07D213/64 , C07D213/643 , C07D213/70 , C07D213/71 , C07D213/74 , C07D213/75 , C07D213/76 , C07D239/47 , C07D241/44 , C07D277/46 , C07D277/52 , C07D277/62 , C07D277/66 , C07D277/82 , C07D295/135 , C07D401/12
摘要： The present invention provides a cytokine production inhibitor containing as an active ingredient an aniline derivative of the formula (I) or a salt thereof: [wherein A is CO or SO2; Cy is an aryl group or a heterocyclic group; each of R1 and R2 which are independent of each other, is a halogen atom, a cyano group, a nitro group, an alkyl group which may be substituted, an alkenyl group which may be substituted, an alkynyl group which may be substituted, a cycloalkyl group which may be substituted, a cycloalkenyl group which may be substituted, an aryl group which may be substituted, a heterocyclic group which may be substituted, an amino group which may be substituted or a —B-Q group; R3 is a -M1-M2-R5 group; R4 is a hydrogen atom or an alkyl group which may be substituted; x is an integer of from 0 to 5; y is an integer of from 0 to 4; and z is an integer of from 0 to 1].
摘要翻译：本发明提供含有作为活性成分的式（I）的苯胺衍生物或其盐的细胞因子产生抑制剂：其中A为CO或SO 2; Cy是芳基或杂环基; R 1和R 2彼此独立的是卤素原子，氰基，硝基，可以被取代的烷基，可被取代的烯基，可被取代的炔基，可被取代的环烷基，可被取代的环烯基，可被取代的芳基，可被取代的杂环基，氨基其可以被取代或-BQ基团; R 3是一个-M 1 -M 2 -OR 5基团; R 4是氢原子或可被取代的烷基; x为0〜5的整数; y为0〜4的整数; z为0〜1的整数]。

7. 发明申请

US20100160326A1 PEST CONTROL AGENT CONTAINING NOVEL PYRIDYL-METHANAMINE DERIVATIVE OR SALT THEREOF 审中-公开
标题翻译：含有新型吡啶基 - 甲胺衍生物或其盐的试剂控制剂
公开(公告)号：US20100160326A1
公开(公告)日：2010-06-24
申请号：US12305664
申请日：2007-07-20
申请人： Hirohiko Kimura , Masayuki Morita , Kazuhiro Yamamoto , Toshihiko Ueki , Kumiko Azuma , Taku Hamamoto
发明人： Hirohiko Kimura , Masayuki Morita , Kazuhiro Yamamoto , Toshihiko Ueki , Kumiko Azuma , Taku Hamamoto
IPC分类号： A01N43/86 , C07D213/02 , A01N43/40 , C07D215/12 , A01N43/42 , C07D265/30 , C07D233/96 , A01N43/54 , C07D241/20 , A01N43/60 , A01P7/00
CPC分类号： C07D213/85 , A01N43/40 , A01N43/42 , A01N43/54 , A01N43/56 , A01N43/60 , A01N43/78 , A01N43/80 , A01N43/82 , A01N43/84 , A01N43/90 , C07D213/74 , C07D213/80 , C07D213/82 , C07D213/84 , C07D401/14 , C07D405/14 , C07D411/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要： A novel pesticide is provided. The present invention provides a pesticide containing, as an active ingredient, a pyridyl-methanamine derivative represented by the formula (I) or its salt: wherein R1 is hydrogen, alkyl, alkenyl, alkynyl, aryl, a heterocyclic group, etc.; each of R2 and R3 which are independent of each other, is hydrogen, halogen, cyano, nitro, alkyl, cycloalkyl, alkenyl, alkynyl, aryl, a heterocyclic group, etc.; R4 is trifluoromethyl or chlorodifluoromethyl; R5 is hydrogen, halogen, cyano, nitro, alkyl, etc.; each of R6 and R7 which are independent of each other, is hydrogen, cyano, alkyl, haloalkyl, etc.; R8 is alkyl, cycloalkyl, alkoxyalkyl, alkoxyalkoxyalkyl, hydroxyalkyl, halogen, haloalkyl, cyano, nitro, etc.; and n is an integer of from 0 to 4.
摘要翻译：提供了一种新型农药。本发明提供含有式（I）表示的吡啶基 - 甲胺衍生物或其盐的农药：其中R1是氢，烷基，烯基，炔基，芳基，杂环基等; R 2和R 3各自独立地为氢，卤素，氰基，硝基，烷基，环烷基，烯基，炔基，芳基，杂环基等。 R4是三氟甲基或氯二氟甲基; R5是氢，卤素，氰基，硝基，烷基等; R 6和R 7各自独立地为氢，氰基，烷基，卤代烷基等; R8是烷基，环烷基，烷氧基烷基，烷氧基烷氧基烷基，羟基烷基，卤素，卤代烷基，氰基，硝基等; n为0〜4的整数。

8. 发明授权

US5492908A Diaminotrifluoromethylpyridine derivatives, process for their production and phospholipase A.sub.2 inhibitor containing them 失效
标题翻译：二氨基三氟甲基吡啶衍生物，其制备方法和含有它们的磷脂酶A2抑制剂
公开(公告)号：US5492908A
公开(公告)日：1996-02-20
申请号：US285271
申请日：1994-08-03
申请人： Takahiro Haga , Hideo Sugi , Itaru Shigehara , Shinji Odawara , Syuichi Yotsuya , Hirohiko Kimura , Kazuhiro Yamamoto
发明人： Takahiro Haga , Hideo Sugi , Itaru Shigehara , Shinji Odawara , Syuichi Yotsuya , Hirohiko Kimura , Kazuhiro Yamamoto
IPC分类号： A61K31/4427 , A61P5/48 , A61P29/00 , C07D213/75 , C07D213/76 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D453/02 , C07D495/04 , A61K31/44 , A61K31/495 , A61K31/54
CPC分类号： C07D213/75 , C07D213/76 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/10 , C07D413/12 , C07D417/12 , C07D453/02 , C07D495/04
摘要： A method of treating rheumatoid arthritis using a diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: ##STR1## wherein X is --CW.sup.1 R.sup.1, --COCOR.sup.2, --CW.sup.1 NHCOR.sup.2, --C(.dbd.W.sup.1)W.sup.2 R.sup.3 or --CW.sup.1 N(R.sup.4)R.sup.5, and Y is alkyl, --CW.sup.3 R.sup.6, --COCOR.sup.7, --NHCOR.sup.7, --C(.dbd.W.sup.3)W.sup.4 R.sup.8, --(NH).sub.m SO.sub.2 R.sup.9, --(NH).sub.m SO.sub.2 OR.sup.10 or --(NH).sub.m SO.sub.2 N(R.sup.11)R.sup.12, wherein each of R.sup.1, R.sup.6 and R.sup.9, which are independent from one another, is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon group which may be substituted, a monocyclic heterocycle group which may be substituted or a polycyclic heterocycle group which may be substituted as further defined herein.
摘要翻译：一种使用式（I）的二氨基三氟甲基吡啶衍生物或其盐进行类风湿性关节炎的方法：其中X为-CW1R1，-COCOR2，-CW1NHCOR2，-C（= W1）W2R3或-CW1N（R4 ）R5，Y是烷基，-CW3R6，-COCOR7，-NHCOR7，-C（= W3）W4R8， - （NH）mSO2R9， - （NH）mSO2OR10或 - （NH）mSO2N（R11）R12， R 1，R 6和R 9彼此独立地是可以被取代的链状烃基，可以被取代的单环烃基，可以被取代的多环烃基，可被取代的单环杂环基或可以如本文进一步定义的可被取代的多环杂环基团。

9. 发明授权

US5348967A Diaminotrifluoromethylpyridine derivatives, process for their production and phospholipase A.sub.2 inhibitor containing them 失效
标题翻译：二氨基三氟甲基吡啶衍生物，其制备方法和含有它们的磷脂酶A2抑制剂
公开(公告)号：US5348967A
公开(公告)日：1994-09-20
申请号：US35622
申请日：1993-03-23
申请人： Takahiro Haga , Hideo Sugi , Itaru Shigehara , Shinji Odawara , Syuichi Yotsuya , Hirohiko Kimura , Kazuhiro Yamamoto
发明人： Takahiro Haga , Hideo Sugi , Itaru Shigehara , Shinji Odawara , Syuichi Yotsuya , Hirohiko Kimura , Kazuhiro Yamamoto
IPC分类号： A61K31/4427 , A61P5/48 , A61P29/00 , C07D213/75 , C07D213/76 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D453/02 , C07D495/04 , A61K31/44
CPC分类号： C07D213/75 , C07D213/76 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/10 , C07D413/12 , C07D417/12 , C07D453/02 , C07D495/04
摘要： A diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: ##STR1## wherein X is --CW.sup.1 R.sup.1, --COCOR.sup.2, --CW.sup.1 NHCOR.sup.2, --C(.dbd.W.sup.1)W.sup.2 R.sup.3 or --CW.sup.1 N(R.sup.4)R.sup.5, and Y is alkyl, --CW.sup.3 R.sup.6, --COCOR.sup.7, --NHCOR.sup.7, --C(.dbd.W.sup.3)W.sup.4 R.sup.8, --(NH).sub.m SO.sub.2 R.sup.9, --(NH).sub.m SO.sub.2 OR.sup.10 or --(NH).sub.m SO.sub.2 N(R.sup.11)R.sup.12, as defined herein.
摘要翻译：式（I）的二氨基三氟甲基吡啶衍生物或其盐：其中X为-CW1R1，-COCOR2，-CW1NHCOR2，-C（= W1）W2R3或-CW1N（R4）R5，Y为烷基，-CW 3 R 6，-COCOR 7，-NHCOR 7，-C（= W 3）W 4 R 8， - （NH）m SO 2 R 9， - （NH）m SO 2 OR 10或 - （NH）m SO 2 N（R 11）R 12。

10. 发明授权

US5260320A Diaminotrifluoromethylpyridine compounds and phospholipase A.sub.2 inhibitor containing them 失效
标题翻译：二氨基三氟甲基吡啶化合物和含有它们的磷脂酶A2抑制剂
公开(公告)号：US5260320A
公开(公告)日：1993-11-09
申请号：US921083
申请日：1992-07-29
申请人： Takahiro Haga , Hideo Sugi , Itaru Shigehara , Shinji Odawara , Syuichi Yotsuya , Hirohiko Kimura , Kazuhiro Yamamoto
发明人： Takahiro Haga , Hideo Sugi , Itaru Shigehara , Shinji Odawara , Syuichi Yotsuya , Hirohiko Kimura , Kazuhiro Yamamoto
IPC分类号： C07D213/75 , C07D213/76 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D453/02 , C07D495/04 , A61K31/44
CPC分类号： C07D213/75 , C07D213/76 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/10 , C07D417/12 , C07D453/02 , C07D495/04
摘要： A diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: ##STR1## wherein X is --CW.sup.1 R.sup.1, --COCOR.sup.2, --CW.sup.1 NHCOR.sup.2, --C(.dbd.W.sup.1)W.sup.2 R.sup.3 or --CW.sup.1 N(R.sup.4)R.sup.5, and Y is alkyl, --CW.sup.3 R.sup.6, --COCOR.sup.7, --NHCOR.sup.7, --C(.dbd.W.sup.3)W.sup.4 R.sup.8, --(NH).sub.m SO.sub.2 R.sup.9, --(NH).sub.m SO.sub.2 OR.sup.10 or --(NH).sub.m SO.sub.2 N(R.sup.11)R.sup.12, wherein each of R.sup.1, R.sup.6 and R.sup.9, which are independent from one another, is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon group which may be substituted, a monocyclic heterocycle group which may be substituted or a polycyclic heterocycle group which may be substituted, each of R.sup.2 and R.sup.7, which are independent from each other, is alkyl which may be substituted, alkoxy which may be substituted, phenyl which may be substituted or phenoxy which may be substituted, each of R.sup.3, R.sup.8 and R.sup.10, which are independent from one another, is alkyl which may be substituted, alkenyl which may be substituted, alkynyl which may be substituted, cycloalkyl which may be substituted, phenyl which may be substituted or benzyl which may be substituted, each of R.sup.4, R.sup.5, R.sup.11 and R.sup.12, which are independent from one another, is alkyl which may be substituted, each of W.sup.1, W.sup.2, W.sup.3 and W.sup.4, which are independent from one another, is an oxygen atom or a sulfur atom, and m is 0 or 1, provided that a combination wherein one of X and Y is --COCF.sub.2 X.sup.1 wherein X.sup.1 is a hydrogen atom, a halogen atom, alkyl or haloalkyl, and the other is --COCF.sub.2 X.sup.2 wherein X.sup.2 is a hydrogen atom, a halogen atom, alkyl, haloalkyl or alkylcarbonyl, or --COOX.sup.3 wherein X.sup.3 is alkyl which may be substituted or phenyl which may be substituted, is excluded.
摘要翻译：式（I）的二氨基三氟甲基吡啶衍生物或其盐：其中X为-CW1R1，-COCOR2，-CW1NHCOR2，-C（= W1）W2R3或-CW1N（R4）R5，Y为烷基，-CW 3 R 6，-COCOR 7，-NHCOR 7，-C（= W3）W 4 R 8， - （NH）m SO 2 R 9， - （NH）m SO 2 OR 10或 - （NH）m SO 2 N（R 11）R 12，其中R 1，R 6和R 9各自彼此独立，可以被取代的链状烃基，可以被取代的单环烃基，可以被取代的多环烃基，可以被取代的单环杂环基或可以被取代的多环杂环基取代的，R 2和R 7各自独立地为可以被取代的烷基，可以被取代的烷氧基，可以被取代的苯基或可被取代的苯氧基，R 3，R 8和R 10各自为彼此独立地是可以被取代的烷基，可以被取代的链烯基，可被取代的炔基，其中的环烷基可被取代的苯基或可被取代的苄基，R 4，R 5，R 11和R 12各自彼此独立地是可以被取代的烷基，各自为W1，W2，W3和W4，其彼此独立的是氧原子或硫原子，并且m为0或1，条件是其中X和Y之一是-COCF 2 X 1的组合，其中X 1是氢原子，卤素原子，烷基或卤代烷基另一个是-COCF 2 X 2，其中X 2是氢原子，卤原子，烷基，卤代烷基或烷基羰基，或-COOX 3，其中X 3是可被取代的烷基或可被取代的苯基。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式